Blanchard R, Berger W, Bailie G R, Eisele G
Department of Pharmacy Practice, Albany College of Pharmacy, NY 12208.
Clin Nephrol. 1990 Oct;34(4):173-8.
A questionnaire was designed to determine and compare the extent of knowledge of 40 continuous ambulatory peritoneal dialysis (CAPD) and 40 hemodialysis (HD) patients about their medicines. It was administered orally to outpatients attending a clinic by an investigator unknown to the patients. Data were collected pertaining to the following target drugs: calcium supplements, phosphate binders, vitamins B and C and folic acid. HD and CAPD groups were closely matched for age and sex. Sixty percent of CAPD and 49% of HD patients were taking four or more medications. The dose of folic acid was accurately recalled by 91% and 71% of CAPD and HD patients. Indications for calcium supplements and phosphate binders were known by only 8% and 30% of CAPD patients compared to 72% and 73% of HD patients. More HD patients knew the indications for all target drugs (p less than 0.01). More CAPD than HD patients knew the expected duration of therapy (p less than 0.01). There was a trend between decreased knowledge of whether the medication was working with increasing age of CAPD patients. Most drug information was supplied by physicians, but many CAPD patients (21%) obtained information from lay sources. When given the opportunity to ask questions about their medicines, only 56% CAPD and 46% HD patients did so. The knowledge of CAPD and HD patients studied was grossly deficient in terms of indications, effectiveness, duration and action to be taken if doses were missed.
设计了一份问卷,以确定并比较40名持续性非卧床腹膜透析(CAPD)患者和40名血液透析(HD)患者对其所用药物的了解程度。该问卷由患者不认识的调查员对门诊患者进行口头询问。收集了以下目标药物的数据:钙补充剂、磷结合剂、维生素B、维生素C和叶酸。HD组和CAPD组在年龄和性别方面进行了严格匹配。60%的CAPD患者和49%的HD患者正在服用四种或更多药物。91%的CAPD患者和71%的HD患者能准确回忆起叶酸的剂量。与72%的HD患者和73%的HD患者相比,只有8%的CAPD患者知道钙补充剂的适应证,30%的CAPD患者知道磷结合剂的适应证。更多的HD患者知道所有目标药物的适应证(p<0.01)。知道治疗预期持续时间的CAPD患者比HD患者更多(p<0.01)。CAPD患者中,随着年龄增长,对药物是否有效的了解呈下降趋势。大多数药物信息由医生提供,但许多CAPD患者(21%)从非专业渠道获取信息。当有机会询问有关他们所用药物的问题时,只有56%的CAPD患者和46%的HD患者这样做了。就适应证、有效性、持续时间以及漏服剂量时应采取的措施而言,所研究的CAPD患者和HD患者的知识严重不足。